Article Name Clinical Trials and Research
Nutromics’ Lab-on-a-Patch, a pioneering biosensing platform capable of simultaneously tracking multiple molecular targets through a single wearable device
10th October, 2025
40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial
09th October, 2025
The FDA's Breakthrough Devices Program is intended to expedite the development and FDA review of medical devices granted BDD
08th October, 2025
Mytos, a London-based biotech startup, is tackling this bottleneck head-on with its fully automated, closed manufacturing platform
08th October, 2025
The study, conducted in rats, demonstrated the Nutromics platform's ability to continuously track levels of multiple targets on one device
03rd October, 2025
A turnkey, radiation-free interventional platform designed to bring precision, safety, and real-time imaging to procedures in oncology, pediatrics, and structural heart interventions
03rd October, 2025
The initiative aims to demonstrate that non-invasive urine testing can match the accuracy of traditional cervical swabs while improving accessibility and compliance
03rd October, 2025
The self-collected option allows patients to collect their own sample in private, eliminating the need for a pelvic exam
01st October, 2025
Philips’ new Rembra RT and Areta RT systems are designed to make cancer treatment planning faster and more accurate
29th September, 2025
Argá Medtech, developer of the Coherent Sine-Burst Electroporation™ (CSE™) System—a next-generation PFA platform designed to expand treatment possibilities while simplifying workflows for physicians
29th September, 2025
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety.
23rd September, 2025
The 17,000-woman study, led by Peking University Shenzhen Hospital, sets three world records and integrates PHASiFY™ DNA concentration technology with AI-powered diagnostics to advance scalable, non-invasive screening in line with WHO’s 2030 elimination goals.
23rd September, 2025
The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care.
23rd September, 2025
The study applies PHASE Scientific’s proprietary PHASiFY urine-based DNA concentration technology
22nd September, 2025
The addition of Blue Spark Technologies, Inc. and QT Medical as device partners signals exciting growth for HeartcoR Solutions as a leading core lab for remote patient monitoring (RPM)
19th September, 2025
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe
19th September, 2025
Yang Huang, Head of China Healthcare Research at J.P. Morgan, unpacks how favourable policies, demographic shifts, and global collaborations are shaping the future of biopharma and medtech investment in China.
19th September, 2025
This strategic collaboration aims to advance medical education and clinical training in laparoscopic and minimally invasive surgical techniques
18th September, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer